About Us Resources Catalysts Start Free Trial →

Loading…

Day Trader Sniper provides algorithmic alerts and analysis, not trade advice.
Not financial advice. Trade at your own risk.

Quick Links

Download The App Resources Market Feed Stocks

Catalysts About Us Support Privacy policy Terms of use

©2026 Day Trader Sniper - all rights reserved

Home›Catalysts›Financial Results

Catalyst Category

Financial Results

Live feed of every catalyst classified under Financial Results.

CATALYSTS IN FEED

233

AVG MAX MOVE

+123.8%

POSITIVE MOVES

100%

LARGEST MOVE

+2833.0%

ATM Program Active ATM Program Ended Authorized Shares Increased Buyback Activity Convertible Notes Placed Debt Exchange Offer Debt Redemption Complete Direct Offering Announced Draw Under Credit Facility Earnings Beat Earnings Calendar Reset Earnings Miss Earnings Mixed Earnings Preview Beat Earnings Report Enter Revolving Credit Facility Equity Facility Deal Equity Offering Announced Equity Offering Priced Equity Offering Withdrawn Follow-On Offering Announced Follow-On Offering Launched Guidance Initiated Guidance Raised Guidance Reaffirmed Hedge Gains Realized Interim Results Interim Results Beat Long-Term Targets Reaffirmed Preferred Stock Convert Private Equity Placement Private Placement Private Placement Notes Q Guidance Initiated Raised Outlook Secondary Offering Closed Share Buyback Authorized Special Dividend Paid Term ABS Offering Warrant Agreement Executed Warrants Expire

Range–

Showing 7 of 233

Financial ResultsPrivate PlacementJun 30, 2026 · 7:55am ET

HXHXHaoxin Holdings Ltd

Haoxin Holdings Ltd Secures $31.2 Million in Strategic Financing

Partnership with Mermaid Money to fuel acquisitions and expansion.

Be first on the next Financial Results catalyst.

Day Trader Sniper alerts you the instant a setup like this triggers.

Download Free →

Max move

+45.6%

RVOL

0.8x

Max high

$0.58

Fuel

2m

Financial ResultsPrivate PlacementJun 30, 2026 · 7:55am ET

HXHXHaoxin Holdings Ltd+45.6%

Haoxin Holdings Ltd Secures $31.2 Million in Strategic Financing

RVOL

0.8x

Max high

$0.58

Fuel

2m

Financial ResultsEquity Offering AnnouncedJun 29, 2026 · 4:59pm ET

BiomX Inc. Filed IPO Registration

The company filed a Form S-1 with the SEC.

Financial ResultsEquity Offering AnnouncedJun 29, 2026 · 4:59pm ET

PHGEBiomX Inc.+31.2%

BiomX Inc. Filed IPO Registration

Financial ResultsPrivate Equity PlacementJun 29, 2026 · 4:03am ET

DCOYDecoy Therapeutics Inc.

Decoy Therapeutics Enters Into $21 Million Private Placement Agreement

Reported Friday

Financial ResultsPrivate Equity PlacementJun 29, 2026 · 4:03am ET

DCOYDecoy Therapeutics Inc.+183.0%

Decoy Therapeutics Enters Into $21 Million Private Placement Agreement

Financial ResultsATM Program EndedJun 25, 2026 · 12:10pm ET

COCHEnvoy Medical, Inc.

Envoy Medical Terminates $15M ATM Equity Facility

Company halts offering of up to 15 million common shares.

Financial ResultsATM Program EndedJun 25, 2026 · 12:10pm ET

COCHEnvoy Medical, Inc.+31.3%

Envoy Medical Terminates $15M ATM Equity Facility

Financial ResultsPrivate Equity PlacementJun 24, 2026 · 4:06pm ET

AZIAutozi Internet Technology (Global) Ltd.

Autozi Internet Technology (Global) Ltd. Enters Securities Purchase Agreement

Company issues advance promissory note to institutional investor.

Financial ResultsPrivate Equity PlacementJun 24, 2026 · 4:06pm ET

AZIAutozi Internet Technology (Global) Ltd.+107.0%

Autozi Internet Technology (Global) Ltd. Enters Securities Purchase Agreement

Financial ResultsPrivate PlacementJun 24, 2026 · 7:01am ET

CALCCalciMedica, Inc.

CalciMedica, Inc. Amends Loan Documents

The company filed an 8-K detailing the amendment.

Financial ResultsPrivate PlacementJun 24, 2026 · 7:01am ET

CALCCalciMedica, Inc.+71.3%

CalciMedica, Inc. Amends Loan Documents

Financial ResultsEquity Offering PricedJun 24, 2026 · 6:36am ET

Absci Corp Announces Interim Phase 1 Data from HEADLINE™ Trial of ABS-201

Company revealed results on June 24, 2026.

Financial ResultsEquity Offering PricedJun 24, 2026 · 6:36am ET

ABSIAbsci Corp+47.0%

Absci Corp Announces Interim Phase 1 Data from HEADLINE™ Trial of ABS-201

1
…
14
15
16
…
34

RVOL

9.9x

Max high

$0.45

Fuel

42m

RVOL

4.3x

Max high

$18.96

Fuel

40m

RVOL

4.0x

Max high

$0.90

Fuel

11m

RVOL

2.9x

Max high

$2.38

Fuel

2h 45m

RVOL

6.6x

Max high

$6.85

Fuel

11m

RVOL

3.1x

Max high

$11.00

Fuel

7h 9m